SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-001435
Filing Date
2021-01-20
Accepted
2021-01-20 16:15:09
Documents
8
Period of Report
2021-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 39781
2 ex1-1.htm EX-1.1 448617
3 ex5-1.htm EX-5.1 23835
4 ex99-1.htm EX-99.1 10388
5 ex99-2.htm EX-99.2 12089
6 ex5-1_001.jpg GRAPHIC 8098
7 ex99-1_001.jpg GRAPHIC 3675
8 ex99-2_001.jpg GRAPHIC 3675
  Complete submission text file 0001493152-21-001435.txt   557599
Mailing Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 21538912
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences